Clinical Trial Update: Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on iron chelation therapy using Deferasirox, Deferoxamine, and their combination in thalassemia patients (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia

Drugs mentioned

• Deferasirox (Deferasirox)
• Deferoxamine (deferoxamine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Thalassemia | Phase 1, Phase 2 | Status: UNKNOWN